This is a notice of intent, not a request for a proposal. A solicitation document will not be issued and proposals will not be requested. The National Institute on Drug Abuse (NIDA), Station Support/Simplified Acquisition (SS/SA) Branch, on behalf of the National Institute on Mental Health (NIMH) intends to solicit, negotiate and award a purchase order on a noncompetitive basis to Matrics Assessment, Los Angeles, CA, for the development of translated and validated versions of the MATRICS Consensus Cognitive Battery (MCCB) to facilitate evaluation of potential new treatments for cognitive impairment in schizophrenia in languages other than English. The period of performance is 12 months with the option for up to two additional 12 month periods. Delivery is Bethesda, Maryland. MATRICS Assessment is a non-profit company and is the only entity that has legal permission to publish the MCCB and to conduct any translations. Therefore based on the aforementioned facts, only one responsible source and no other supplies or services will satisfy agency requirements FAR 6.302-1. The Government intends to select the offer that represents the best value to the Government, price and all other factors considered. The acquisition is being conducted under simplified acquisition FAR 13.5 and is exempt from the requirements of FAR Part 6, Competition Requirement. This notice of intent is not a request for competitive proposals. Interested parties may identify their interest and capabilities in response to this synopsis. The determination by the Government not to compete the proposed contract based upon responses to this notice is solely with the discretion of the Government. Comments to this announcement, referencing synopsis number NOI70112 may be submitted to the NIDA, SS/SA Branch, 31 Center Drive, Room 1B59, Bethesda, MD 20892, Attention: Susan A. Nsangou.

Bid Protests Not Available